Morgan Stanley’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $256M | Buy |
|
|||||
|
2025
Q2 | $229M | Buy |
|
|||||
|
2025
Q1 | $168M | Sell |
|
|||||
|
2024
Q4 | $215M | Buy |
|
|||||
|
2024
Q3 | $155M | Sell |
|
|||||
|
2024
Q2 | $213M | Sell |
|
|||||
|
2024
Q1 | $285M | Sell |
|
|||||
|
2023
Q4 | $613M | Buy |
|
|||||
|
2023
Q3 | $216M | Buy |
|
|||||
|
2023
Q2 | $176M | Buy |
|
|||||
|
2023
Q1 | $168M | Sell |
|
|||||
|
2022
Q4 | $245M | Buy |
|
|||||
|
2022
Q3 | $57M | Buy |
|
|||||
|
2022
Q2 | $47.5M | Buy |
|
|||||
|
2022
Q1 | $16.6M | Buy |
|
|||||
|
2021
Q4 | $11.9M | Sell |
|
|||||
|
2021
Q3 | $13.9M | Sell |
|
|||||
|
2021
Q2 | $34M | Buy |
|
|||||
|
2021
Q1 | $10.7M | Sell |
|
|||||
|
2020
Q4 | $12M | Sell |
|
|||||
|
2020
Q3 | $27.2M | Buy |
|
|||||
|
2020
Q2 | $17.8M | Buy |
|
|||||
|
2020
Q1 | $7.05M | Sell |
|
|||||
|
2019
Q4 | $17.1M | Buy |
|
|||||
|
2019
Q3 | $7.47M | Buy |
|
|||||
|
2019
Q2 | $4.95M | Sell |
|
|||||
|
2019
Q1 | $7.85M | Sell |
|
|||||
|
2018
Q4 | $11.2M | Sell |
|
|||||
|
2018
Q3 | $26.3M | Buy |
|
|||||
|
2018
Q2 | $9.49M | Sell |
|
|||||
|
2018
Q1 | $15.3M | Buy |
|
|||||
|
2017
Q4 | $3.97M | Buy |
|
|||||
|
2017
Q3 | $2.23M | Sell |
|
|||||
|
2017
Q2 | $2.44M | Buy |
|
|||||
|
2017
Q1 | $1.33M | Sell |
|
|||||
|
2016
Q4 | $1.83M | Buy |
|
|||||
|
2016
Q3 | $2.06M | Sell |
|
|||||
|
2016
Q2 | $2.92M | Buy |
|
|||||
|
2016
Q1 | $1.48M | Sell |
|
|||||
|
2015
Q4 | $3.72M | Buy |
|
|||||
|
2015
Q3 | $1.87M | Buy |
|
|||||
|
2015
Q2 | $1.47M | Sell |
|
|||||
|
2015
Q1 | $4.16M | Buy |
|
|||||
|
2014
Q4 | $2.2M | Buy |
|
|||||
|
2014
Q3 | $787K | Buy |
|
|||||
|
2014
Q2 | $516K | Buy |
|
|||||
|
2014
Q1 | $340K | Sell |
|
|||||
|
2013
Q4 | $467K | Buy |
|
|||||
|
2013
Q3 | $520K | Sell |
|
|||||
|
2013
Q2 | $932K | Buy |
|